SCHEMBL9729808

SCHEMBL9729808

O=C1CCC(c2ccccc2)(c2ccccc2)C2CN(C(=O)Cc3ccccn3)CC12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 4/20 0.52
MEN1 O00255 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAPT P10636 1/20 0.52
TSHR P16473 1/20 0.52
CYP2C19 P33261 1/20 0.52
KMT2A Q03164 1/20 0.52
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
FNTA P49354 3/20 0.37
FNTB P49356 3/20 0.37
CNR1 P21554 1/20 0.37
KDM1A O60341 1/20 0.37
PARP1 P09874 1/20 0.37
NAMPT P43490 1/20 0.36
TLR2 O60603 1/20 0.35
TLR1 Q15399 1/20 0.35
PAX8 Q06710 1/20 0.35
KDR P35968 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9730595 0.85 TACR1 (0.58) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9729849 0.85 TACR1 (0.58) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9729733 0.82 TACR1 (0.47) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9729215 0.82 TACR1 (0.51) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9729456 0.81 TACR1 (0.59) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9730103 0.80 MAPT (0.56) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9730227 0.80 TACR1 (0.53) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9729985 0.80 TACR1 (0.58) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9729329 0.80 TACR1 (0.58) TACR1MEN1CYP3A4MAPTTSHR
SCHEMBL9730246 0.80 TACR1 (0.58) TACR1MEN1CYP3A4MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5102667-A Antiallergens, antiinflammatory agents, nervous system disorders, immunology, psychological disorders RHONE-POULENC SANTE (FR) 1992-04-07 US disclosed